Results 51 to 60 of about 1,215,873 (292)
Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose
Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...Benjamin J. Lerman, Madeleine King, Rajen Mody, Sara‐Jane Onyeama, Araz Marachelian, Thomas Cash, Sara M. Federico, Meaghan Granger, Ami V. Desai, Suzanne Shusterman, Jennifer H. Foster, Elizabeth Sokol, Chelsee Greer, Keri Streby, Holly J. Meany, Kieuhoa T. Vo, Margaret E. Macy, Rochelle Bagatell +17 morewiley +1 more sourceAlveolar Soft Part Sarcoma in Pediatric and Young Adult Patients: A Report From the Children's Oncology Group Study ARST0332
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
Alveolar soft part sarcoma (ASPS) is a rare soft tissue sarcoma occurring most commonly in adolescence and young adulthood. Methods
We present the clinical characteristics, treatments, and outcomes of patients with newly diagnosed ASPS enrolled on the Children's Oncology Group study ARST0332.Jacquelyn N. Crane, Wei Xue, Amira Qumseya, Thomas Scharschmidt, Kathryn R. Tringale, Oscar Lopez Nunez, Jiaqi Hu, Donald A. Barkauskas, Rajkumar Venkatramani, Sheri L. Spunt, Aaron R. Weiss, Noah C. Federman +11 morewiley +1 more sourceImplementing Health‐Related Quality of Life Assessment in Pediatric Oncology: A Feasibility Study
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
There is growing interest in embedding health‐related quality of life (HRQoL) assessment and patient‐reported outcome measures (PROMs) within clinical cancer care. This study evaluated the feasibility, acceptability, and usability of implementing an electronic PROM (ePROM) platform to measure HRQoL in children with cancer ...
Mikaela Doig, Sophie Jessop, Jordan R. Hansford, Hien Le, Matthew O'Connor, Peter Gorayski, Andrew Cunningham, Amanda Hutchinson, Victoria Bedford, Eva Bezak, Nayana Parange, Kelly Skelton, Timothy Price, Michala Short +13 morewiley +1 more sourceSuppression of away-side jet fragments with respect to the reaction
plane in Au+Au collisions at sqrt(s_NN) = 200 GeV
, 2010 Pair correlations between large transverse momentum neutral pion triggers
(p_T=4--7 GeV/c) and charged hadron partners (p_T=3--7 GeV/c) in central
(0--20%) and midcentral (20--60%) Au+Au collisions are presented as a function
of trigger orientation with ...Adare, A., Afanasiev, S., Aidala, C., Ajitanand, N. N., Akiba, Y., Al-Bataineh, H., Alexander, J., Aoki, K., Aphecetche, L., Aramaki, Y., Asai, J., Atomssa, E. T., Averbeck, R., Awes, T. C., Azmoun, B., Babintsev, V., Bai, M., Baksay, G., Baksay, L., Baldisseri, A., Barish, K. N., Barnes, P. D., Bassalleck, B., Basye, A. T., Bathe, S., Batsouli, S., Baublis, V., Baumann, C., Bazilevsky, A., Belikov, S., Belmont, R., Bennett, R., Berdnikov, A., Berdnikov, Y., Bickley, A. A., Boissevain, J. G., Bok, J. S., Borel, H., Boyle, K., Brooks, M. L., Buesching, H., Bumazhnov, V., Bunce, G., Butsyk, S., Camacho, C. M., Campbell, S., Chang, B. S., Chang, W. C., Charvet, J. -L., Chen, C. -H., Chernichenko, S., Chi, C. Y., Chiu, M., Choi, I. J., Choudhury, R. K., Christiansen, P., Chujo, T., Chung, P., Churyn, A., Chvala, O., Cianciolo, V., Citron, Z., Cole, B. A., Connors, M., Constantin, P., Csanád, M., Csörgő, T., d'Enterria, D., Dahms, T., Dairaku, S., Danchev, I., Das, K., Datta, A., David, G., de Cassagnac, R. Granier, Denisov, A., Deshpande, A., Desmond, E. J., Dietzsch, O., Dion, A., Donadelli, M., Drapier, O., Drees, A., Drees, K. A., Dubey, A. K., Durham, J. M., Durum, A., Dutta, D., Dzhordzhadze, V., Edwards, S., Efremenko, Y. V., Ellinghaus, F., En'yo, H., Engelmore, T., Enokizono, A., Esumi, S., Eyser, K. O., Fadem, B., Fields, D. E., Finger, Jr., M., Finger, M., Fleuret, F., Fokin, S. L., Fraenkel, Z., Frantz, J. E., Franz, A., Frawley, A. D., Fujiwara, K., Fukao, Y., Fusayasu, T., Garishvili, I., Glenn, A., Gong, H., Gonin, M., Gosset, J., Goto, Y., Grau, N., Greene, S. V., Gunji, T., Gustafsson, H. -Å., Haggerty, J. S., Hahn, K. I., Hamagaki, H., Hamblen, J., Han, R., Hanks, J., Hartouni, E. P., Haruna, K., Haslum, E., Hayano, R., He, X., Heffner, M., Hemmick, T. K., Henni, A. Hadj, Hester, T., Hill, J. C., Hohlmann, M., Holzmann, W., Homma, K., Hong, B., Horaguchi, T., Hornback, D., Huang, S., Ichihara, T., Ichimiya, R., Ide, J., Iinuma, H., Ikeda, Y., Imai, K., Imrek, J., Inaba, M., Isenhower, D., Ishihara, M., Isobe, T., Issah, M., Isupov, A., Ivanischev, D., Jacak, B. V., Jia, J., Jin, J., Johnson, B. M., Joo, K. S., Jouan, D., Jumper, D. S., Kajihara, F., Kametani, S., Kamihara, N., Kamin, J., Kang, J. H., Kapustinsky, J., Karatsu, K., Kawall, D., Kawashima, M., Kazantsev, A. V., Kempel, T., Khanzadeev, A., Kijima, K. M., Kikuchi, J., Kim, B. I., Kim, D. H., Kim, D. J., Kim, E., Kim, E. J., Kim, S. H., Kim, Y. J., Kinney, E., Kiriluk, K., Kiss, Á., Kistenev, E., Klay, J., Klein-Boesing, C., Kochenda, L., Komkov, B., Konno, M., Koster, J., Kotchetkov, D., Kozlov, A., Kravitz, A., Král, A., Kunde, G. J., Kurita, K., Kurosawa, M., Kweon, M. J., Kwon, Y., Kyle, G. S., Lacey, R., Lai, Y. S., Lajoie, J. G., Layton, D., Lebedev, A., Lee, D. M., Lee, J., Lee, K., Lee, K. B., Lee, K. S., Lee, T., Leitch, M. J., Leite, M. A. L., Leitner, E., Lenzi, B., Levy, L. A. Linden, Li, X., Liebing, P., Litvinenko, A., Liu, H., Liu, M. X., Liška, T., Love, B., Luechtenborg, R., Lynch, D., Maguire, C. F., Makdisi, Y. I., Malakhov, A., Malik, M. D., Manko, V. I., Mannel, E., Mao, Y., Masui, H., Matathias, F., Mašek, L., McCumber, M., McGaughey, P. L., Means, N., Meredith, B., Miake, Y., Mignerey, A. C., Mikeš, P., Miki, K., Milov, A., Mishra, M., Mitchell, J. T., Mohanty, A. K., Morino, Y., Morreale, A., Morrison, D. P., Moukhanova, T. V., Mukhopadhyay, D., Murata, J., Nagamiya, S., Nagle, J. L., Naglis, M., Nagy, M. I., Nakagawa, I., Nakamiya, Y., Nakamura, T., Nakano, K., Newby, J., Nguyen, M., Niita, T., Nouicer, R., Nyanin, A. S., O'Brien, E., Oda, S. X., Ogilvie, C. A., Oka, M., Okada, K., Onuki, Y., Oskarsson, A., Ouchida, M., Ozawa, K., Pak, R., Palounek, A. P. T., Pantuev, V., Papavassiliou, V., Park, I. H., Park, J., Park, S. K., Park, W. J., Pate, S. F., Pei, H., Peng, J. -C., Perdekamp, M. Grosse, Pereira, H., Peresedov, V., Peressounko, D. Yu., Pinkenburg, C., Pisani, R. P., Proissl, M., Purschke, M. L., Purwar, A. K., Qu, H., Rak, J., Rakotozafindrabe, A., Ravinovich, I., Read, K. F., Rembeczki, S., Reygers, K., Riabov, V., Riabov, Y., Richardson, E., Roach, D., Roche, G., Rolnick, S. D., Rosati, M., Rosen, C. A., Rosendahl, S. S. E., Rosnet, P., Rukoyatkin, P., Ružička, P., Rykov, V. L., Sahlmueller, B., Saito, N., Sakaguchi, T., Sakai, S., Sakashita, K., Samsonov, V., Sano, S., Sato, T., Sawada, S., Sedgwick, K., Seele, J., Seidl, R., Semenov, A. Yu., Semenov, V., Seto, R., Sharma, D., Shein, I., Shibata, T. -A., Shigaki, K., Shimomura, M., Shoji, K., Shukla, P., Sickles, A., Silva, C. L., Silvermyr, D., Silvestre, C., Sim, K. S., Singh, B. K., Singh, C. P., Singh, V., Slunečka, M., Soldatov, A., Soltz, R. A., Sondheim, W. E., Sorensen, S. P., Sourikova, I. V., Sparks, N. A., Staley, F., Stankus, P. W., Stenlund, E., Stepanov, M., Ster, A., Stoll, S. P., Sugitate, T., Suire, C., Sukhanov, A., Sziklai, J., Takagui, E. M., Taketani, A., Tanabe, R., Tanaka, Y., Tanida, K., Tannenbaum, M. J., Tarafdar, S., Taranenko, A., Tarján, P., Themann, H., Thomas, T. L., Togawa, M., Toia, A., Tomita, Y., Tomášek, L., Torii, H., Towell, R. S., Tram, V-N., Tserruya, I., Tsuchimoto, Y., Vale, C., Valle, H., van Hecke, H. W., Vazquez-Zambrano, E., Veicht, A., Velkovska, J., Vinogradov, A. A., Virius, M., Vrba, V., Vznuzdaev, E., Vértesi, R., Wang, X. R., Watanabe, D., Watanabe, K., Watanabe, Y., Wei, F., Wei, R., Wessels, J., White, S. N., Winter, D., Wood, J. P., Woody, C. L., Wright, R. M., Wysocki, M., Xie, W., Yamaguchi, Y. L., Yamaura, K., Yang, R., Yanovich, A., Ying, J., Yokkaichi, S., You, Z., Young, G. R., Younus, I., Yushmanov, I. E., Zajc, W. A., Zaudtke, O., Zhang, C., Zhou, S., Zolin, L. +426 morecore +3 more sourcesRapid Response to Trametinib Combined With Chemotherapy for Infant BRAF‐Fused Chiasmatic Glioma
Pediatric Blood &Cancer, EarlyView.ABSTRACT
Infants, less than 1 year, with chiasmatic gliomas (ICG) present a major therapeutic challenge due to large tumor size, decreased vision, rapid progression, and poor response to vincristine/carboplatin chemotherapy. The majority have a BRAF fusion, which may respond to downstream MEK inhibitors but response time is slow. There are no safety or Helen Toledano, Alexander Yelak, Walid Kaadan, Shlomo Caduri, Rivka Friedland, Orli Michaeli, Gad Dotan, Osnat Konen +7 morewiley +1 more sourceA Fast Tracking Algorithm for the ATLAS Level 2 Trigger [PDF]
, 2006 A set of conceptually simple and robust algorithms for fast pattern recognition and track reconstruction using 3D space points developed for the ATLAS Level 2 (LVL2) Trigger at the LHC is presented.Baines, J T M, Drevermann, H, Emeliyanov, D, Konstantinidis, N P, Parodi, P, Schiavi, C, Sutton, M +6 morecore A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia
Pediatric Blood &Cancer, EarlyView.ABSTRACT
A second allogeneic (allo‐)hematopoietic stem cell transplantation (HSCT2) is a potential curative option for pediatric patients with acute lymphoblastic leukemia (ALL) following relapse after first allogeneic transplantation (HSCT1), but its efficacy is limited by high relapse rates and transplant‐related toxicity in highly pretreated ...Ava Momm, Imme Haubitz, Rita Beier, Martin Zimmermann, Andrej Lissat, Peter Bader, Matthias Eyrich, Jan‐Henning Klusmann, Matthias Wölfl, Paul‐Gerhardt Schlegel, Verena Wiegering +10 morewiley +1 more source
